News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Estela Rodriguez: When more is not necessarily better – SBRT vs conventional RT for Painful Bone Metastases
Estela Rodriguez/X
May 13, 2025, 15:16

Estela Rodriguez: When more is not necessarily better – SBRT vs conventional RT for Painful Bone Metastases

Estela Rodriguez, Associate Director of Community Outreach and Co-Lead Thoracic Site Disease Group of the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, shared a post on X:

“When more is not necessarily better: SBRT vs conventional RT for Painful Bone Metastases (ROBOMET): A Multicenter, Patient-Blinded Randomized Clinical Trial
(N=126) SBRT failed to demonstrate statistically significant improvement in CR rates after 1 month.”

Title: Dose-Escalated Stereotactic Versus Conventional Radiotherapy for Painful Bone Metastases (ROBOMET): A Multicenter, Patient-Blinded Randomized Clinical Trial

Authors: Carole Mercier, Charlotte Billiet, Piet Ost, Katrien Vandecasteele, Geert De Kerf, Michaël Claessens, Steven Van Laere, Peter Vermeulen, Luc Dirix, Yolande Lievens, Dirk Verellen, Piet Dirix

Read the Full Article in Journal of Clinical Oncology.

Estela Rodriguez

cancer Carole Mercier Charlotte Billiet Dirk Verellen Estela Rodriguez Geert De Kerf Katrien Vandecasteele Luc Dirix Michaël Claessens OncoDaily Oncology Peter Vermeulen Piet Dirix Piet Ost Steven Van Laere Yolande Lievens
Special Coverage
Radiotherapy
Aug 5, 2025, 23:32
New RT Paper Alert: No Survival Benefit for Zalutumumab in Head And Neck Cancer
Blog
Aug 5, 2025, 20:55
Niranjala Siriwardena: When Hospitals Offer Compassion, Workplaces Offer HR Meetings
Blog
Aug 5, 2025, 20:43
Niranjala Siriwardena: Rewriting What Survivorship Looks Like in Australia and Beyond
Blog
Aug 5, 2025, 20:19
Niranjala Siriwardena: Australia Still Has No Workplace Cancer Survivorship Policy
Blog
Aug 5, 2025, 20:02
Voice of the Families: Mumbere’s Journey with Burkitt Lymphoma - CANCaRe Africa
Science
Aug 5, 2025, 19:50
Nicola Fusco: How Reliable Is ESR1 Mutation Testing in Liquid Biopsy for ER+/HER2- mBC?
Science
Aug 5, 2025, 19:24
Miguel Bronchud: Underestimation of Risk by Biopsies Alone Could Lead to Undertreatment in Prostate Cancer
Blog
Aug 5, 2025, 19:11
Miriam Mutebi: What Legacy Truly Means for African Leadership in Cancer Care
Insight
Aug 5, 2025, 18:55
Svetlana Nikic: Women Leading the Next Era of Cancer Care
Blog
Aug 5, 2025, 18:40
Upcoming Grand Rounds on the Future of Artificial Intelligence in Oncology - IOWG
Blog
Aug 5, 2025, 18:30
It’s Time to Move from Awareness to Action - ELPA
Blog
Aug 5, 2025, 18:18
Manoj Reddy: IOWG Grand Rounds Return after A Summer Break